An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 16, Pages e2101852118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-04-14
DOI
10.1073/pnas.2101852118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FAP: The Next Billion Dollar Nuclear Theranostics Target?
- (2020) Jeremie Calais JOURNAL OF NUCLEAR MEDICINE
- A universal reporter cell line for bioactivity evaluation of engineered cytokine products
- (2020) Jacqueline Mock et al. Scientific Reports
- Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
- (2020) M. Syed et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
- (2020) Michael S Hofman et al. LANCET
- MMAE delivery using the Bicycle toxin conjugate BT5528
- (2020) Gavin Bennett et al. MOLECULAR CANCER THERAPEUTICS
- Impact of Ligand Size and Conjugation Chemistry on the Performance of Universal Chimeric Antigen Receptor T-Cells for Tumor Killing
- (2020) Christian Pellegrino et al. BIOCONJUGATE CHEMISTRY
- A microdosing study with 99mTc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients
- (2020) Oana Cristina Kulterer et al. JOURNAL OF NUCLEAR MEDICINE
- Immunotherapy with immunocytokines and PD-1 blockade enhances the anticancer activity of Small Molecule-Drug Conjugates targeting Carbonic Anhydrase IX
- (2020) Jacopo Millul et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor effects of CAR T cells redirected to the EDB splice variant of fibronectin
- (2020) Jessica Wagner et al. Cancer Immunology Research
- FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer
- (2019) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- FDA 's and EMA 's approval of brentuximab vedotin for advanced Hodgkin lymphoma: another player in the town?
- (2019) Vibor Milunović et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2019) Laurie H. Sehn et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation dosimetry and biodistribution of 68Ga-FAPI-46 PET imaging in cancer patients
- (2019) Catherine Meyer et al. JOURNAL OF NUCLEAR MEDICINE
- Theranostic radiopharmaceuticals: established agents in current use
- (2018) James R Ballinger BRITISH JOURNAL OF RADIOLOGY
- Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2
- (2018) Samuele Cazzamalli et al. CLINICAL CANCER RESEARCH
- Development of quinoline based theranostic ligands for the targeting of fibroblast activation protein
- (2018) Thomas Lindner et al. JOURNAL OF NUCLEAR MEDICINE
- Chemically Defined Antibody– and Small Molecule–Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis
- (2018) Samuele Cazzamalli et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- PSMA Theranostics: Current Status and Future Directions
- (2018) Kambiz Rahbar et al. Molecular Imaging
- Use of a Single CAR T Cell and Several Bispecific Adapters Facilitates Eradication of Multiple Antigenically Different Solid Tumors
- (2018) Yong Gu Lee et al. CANCER RESEARCH
- Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives
- (2018) Aura D. Herrera-Martínez et al. DRUGS
- Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment
- (2018) Chunlin Zhuang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging
- (2017) John Y. K. Lee et al. JOURNAL OF NEUROSURGERY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design of a Small-Molecule Drug Conjugate for Prostate Cancer Targeted Theranostics
- (2016) Amit Kumar et al. BIOCONJUGATE CHEMISTRY
- A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer
- (2016) C. E. S. Hoogstins et al. CLINICAL CANCER RESEARCH
- Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti–Fibroblast Activation Protein Antibody
- (2016) Tessa van der Geest et al. JOURNAL OF NUCLEAR MEDICINE
- Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins
- (2016) Alison Smith et al. Journal of Immunology Research
- Selective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) Ligand
- (2015) Charity Wayua et al. MOLECULAR PHARMACEUTICS
- Targeting Carbonic Anhydrase IX Activity and Expression
- (2015) Brian Mahon et al. MOLECULES
- Principles in the design of ligand-targeted cancer therapeutics and imaging agents
- (2015) Madduri Srinivasarao et al. NATURE REVIEWS DRUG DISCOVERY
- A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity
- (2015) De-Gang Song et al. Oncotarget
- Small Targeted Cytotoxics: Current State and Promises from DNA-Encoded Chemical Libraries
- (2013) Nikolaus Krall et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
- (2013) R. Wendel Naumann et al. JOURNAL OF CLINICAL ONCOLOGY
- Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin-Positive Metastatic Human Melanoma Xenografts
- (2012) M. Moschetta et al. CANCER RESEARCH
- Targeted drug delivery for cancer therapy: the other side of antibodies
- (2012) Michael A Firer et al. Journal of Hematology & Oncology
- Rationale Behind Targeting Fibroblast Activation Protein-Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy
- (2012) W. N. Brennen et al. MOLECULAR CANCER THERAPEUTICS
- Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts
- (2008) E. Ostermann et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started